Baby Boomers Have Increased Risk of Rx Opioid Overdose Death

Share this content:
Baby Boomers Have Increased Risk of Rx Opioid Overdose Death
Baby Boomers Have Increased Risk of Rx Opioid Overdose Death

WEDNESDAY, Nov. 22, 2017 (HealthDay News) -- Individuals born between 1947 and 1964 have a significantly increased risk of prescription opioid overdose death and heroin overdose death, and those born from 1979 to 1992 also have an increased risk of heroin overdose death, according to a study published online Nov. 21 in the American Journal of Public Health.

Xiwen Huang, M.P.H., from Columbia University in New York City, and colleagues used data from the National Center for Health Statistics' multiple cause-of-death file for 1999 to 2014 to perform an age-period-cohort analysis of drug overdose mortality.

The researchers found that individuals born between 1947 and 1964 experienced excess risks of prescription opioid overdose death compared with those born in 1977 and 1978 (e.g., rate ratio, 1.27 for the 1955 to 1956 birth cohort); they also had excess risk of heroin overdose death (e.g., rate ratio, 1.32 for the 1953 to 1954 birth cohort). The risk of heroin overdose death was also increased for those born between 1979 and 1992 (e.g., rate ratio, 1.23 for the 1989 to 1990 birth cohort). Consistent effects were seen between the sexes.

"Individuals born between 1947 and 1964 and between 1979 and 1992 are particularly afflicted by the opioid epidemic," the authors write. "Intervention programs are needed to reduce the excess overdose mortality in these specific demographic groups."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell ...

Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

ASH: AAVD Beats ABVD for Advanced Hodgkin's Lymphoma

ASH: A+AVD Beats ABVD for Advanced Hodgkin's Lymphoma

Lower combined risk of progression, death, or noncomplete response with A+AVD

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia ...

Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels

is free, fast, and customized just for you!

Already a member?

Sign In Now »